drugset / Trial / NCT03216304
Safinamide Steady State Interaction With Rosuvastatin
Non-randomizedCrossoverOpen-labelTreatment
Summary
To evaluate if safinamide at the steady state, obtained after multiple 100 mg once a day administrations, has an effect on the pharmacokinetics of rosuvastatin, concomitantly administered as a single 20 mg dose, with respect to the pharmacokinetics of 20 mg rosuvastatin administered alone.
Timeline
- Start
- 2017-05-22
- Primary completion
- 2017-07-06
- Completion
- 2017-07-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Rosuvastatin | Small molecule | 20 mg | Oral |
| Subject | Safinamide | Small molecule | 100 mg | Oral |
Indications
No indication recorded.